SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?


To: Hong-Lee Yu who wrote (646)4/9/1998 3:59:00 PM
From: PawPr  Read Replies (2) | Respond to of 965
 
I agree that the Crohn's disease market is small, but approval will send a message that the FDA does not consider the safety issue ( i.e. the alleged association with
lymphoma ) to be critical. The FDA considers safety AND efficacy, so getting around the lymphoma issue ( which, by the way, I do NOT believe is a side effect of the drug ) is important.

BT